Chief executive
Daniel O'Day
Chairman & CEO · Gilead Sciences, Inc.
19 disclosed trades · 30 May 2025 to 1 Oct 2026 · latest filed 2 Oct 2026
Chief executive of Gilead Sciences, Inc. (GILD), tracked from the executive's own SEC Form 4 disclosures.
Recent disclosed trades
| Company | Trade date | Action | Amount |
|---|---|---|---|
| Common Stock (GILD) | 2026-10-01 | Sell | $2,218,508 |
| Common Stock (GILD) | 2026-09-01 | Sell | $2,229,592 |
| Common Stock (GILD) | 2026-08-03 | Sell | $1,954,694 |
| Common Stock (GILD) | 2026-07-01 | Sell | $1,894,399 |
| Common Stock (GILD) | 2026-06-01 | Sell | $1,971,847 |
| Common Stock (GILD) | 2026-04-28 | Sell | $1,291,609 |
| Common Stock (GILD) | 2026-03-27 | Sell | $1,368,162 |
| Common Stock (GILD) | 2026-02-27 | Sell | $1,447,858 |
| Common Stock (GILD) | 2026-02-05 | Sell | $17,346,000 |
| Common Stock (GILD) | 2026-01-28 | Sell | $1,398,911 |
| Common Stock (GILD) | 2026-01-23 | Sell | $15,611,400 |
| Common Stock (GILD) | 2025-12-29 | Sell | $1,248,272 |
| Common Stock (GILD) | 2025-11-28 | Sell | $1,265,444 |
| Common Stock (GILD) | 2025-10-28 | Sell | $1,193,926 |
| Common Stock (GILD) | 2025-09-29 | Sell | $1,116,564 |
| Common Stock (GILD) | 2025-08-28 | Sell | $1,136,300 |
| Common Stock (GILD) | 2025-07-28 | Sell | $1,139,370 |
| Common Stock (GILD) | 2025-06-30 | Sell | $1,104,484 |
| Common Stock (GILD) | 2025-05-30 | Sell | $1,104,193 |
Source: SEC Form 4 filings, trades from 30 May 2025 to 1 Oct 2026, latest filed 2 Oct 2026. Executives report their own trades on Form 4 within two business days.
Open the interactive profile: all trades, compare with others